Literature DB >> 27436273

A Case of Euglycemic Diabetic Ketoacidosis Following Long-term Empagliflozin Therapy.

Peter D Farjo1, Kacie M Kidd2, Josephine L Reece3.   

Abstract

Entities:  

Year:  2016        PMID: 27436273     DOI: 10.2337/dc16-0728

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  4 in total

1.  Euglycemic ketosis in patients with type 2 diabetes on SGLT2-inhibitor therapy-an emerging problem and solutions offered by diabetes technology.

Authors:  A Pfützner; D Klonoff; L Heinemann; N Ejskjaer; J Pickup
Journal:  Endocrine       Date:  2017-03-17       Impact factor: 3.633

2.  SGLT-2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis: A Case Report and a Literature Review.

Authors:  Rabia Salman Mahfooz; Muhammad Khuzzaim Khan; Hussam Al Hennawi; Anwar Khedr
Journal:  Cureus       Date:  2022-06-23

3.  Prolonged diabetic ketoacidosis associated with canagliflozin.

Authors:  Gordon Sloan; Tania Kakoudaki; Nishant Ranjan
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2018-06-06

4.  Euglycemic Diabetic Ketoacidosis in the ICU: 3 Case Reports and Review of Literature.

Authors:  Pablo Lucero; Sebastián Chapela
Journal:  Case Rep Crit Care       Date:  2018-10-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.